针对肝细胞癌中的glypican-3的组合疗法策略:综合性审查
Sina Nabiyi1, Mohammad Heiat2, Ehsan Rezaei3
1Department of Immunology, School of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran.
Cytokine & growth factor reviews
|December 17, 2025
概括
准Glypican-3 (GPC3) 在肝细胞癌 (HCC) 治疗方面表现有前途. 组合疗法,包括针对GPC3的药物和其他治疗方法,对于改善HCC患者的治疗结果至关重要.
科学领域:
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
- 精准医学是一门精准的医学.
背景情况:
- 肝细胞癌 (HCC) 是全球主要的癌症死亡原因.
- 先进的HCC往往会抵抗传统治疗,需要新的治疗策略.
- Glypican-3 (GPC3) 是一个经过验证的HCC瘤抗原,使其成为精密瘤学的关键目标.
研究的目的:
- 审查各种针对HCC的GPC3向治疗策略.
- 检查将GPC3向药物与其他疗法结合的多模式方法的潜力.
- 突出GPC3向性HCC治疗的挑战和未来方向.
主要方法:
- 审查目前关于GPC3向治疗的研究.
- 分析各种治疗方式,包括细胞免疫疗法,基于抗体的药物和药物输送系统.
- 检查关于组合策略的临床前和临床数据.
主要成果:
- 针对GPC3的治疗包括广泛的方法,如CAR-T细胞治疗和基于抗体的药物.
- 临床翻译受到诸如瘤透率低下和免疫抑制瘤微环境等挑战的阻碍.
- 针对GPC3的药物在与免疫检查点抑制剂,抗血管生成药物和其他疗法相结合时表现出协同效应.
结论:
- 涉及GPC3向药物的组合策略具有显著的潜力,可以提高HCC的抗瘤疗效.
- 通过个性化治疗策略优化这些多式模式治疗方案对于实现持久的临床结果至关重要.
- 对组合疗法的进一步研究对于提高HCC治疗有效性至关重要.
更多相关视频
06:38An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
Published on: September 12, 2019
9.4K
12:24A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
Published on: September 30, 2021
5.9K
相关概念视频
02:57Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
01:27Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
02:49Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K
02:50Combination Therapies and Personalized Medicine
5.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.8K